Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=186"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=186

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00623623-b9ce0959",
        "title": "Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Rehospitalisation for Cardiac Reasons",
        "summary": "45 of 949 against 41 of 948; risk difference 0.4 points, 95% interval -1.5 to 2.3; NCT00623623, STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction",
        "record": "/library/comparisons/NCT00623623-b9ce0959",
        "nct_id": "NCT00623623",
        "kind": "outcome",
        "participants": 1897,
        "risk_difference": {
          "value": 0.004169389941888639,
          "lower": -0.014830286578155369,
          "upper": 0.02325145009135344
        },
        "group_1": "45 of 949",
        "group_2": "41 of 948",
        "difference": "0.4 points",
        "interval": "-1.5 to 2.3",
        "trial_title": "STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction"
      },
      {
        "id": "NCT00623623-c787ae85",
        "title": "Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Rehospitalisation for Non-cardiac Reasons",
        "summary": "19 of 949 against 11 of 948; risk difference 0.8 points, 95% interval -0.3 to 2.1; NCT00623623, STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction",
        "record": "/library/comparisons/NCT00623623-c787ae85",
        "nct_id": "NCT00623623",
        "kind": "outcome",
        "participants": 1897,
        "risk_difference": {
          "value": 0.008417699288169201,
          "lower": -0.0031297120397074333,
          "upper": 0.020581111517223874
        },
        "group_1": "19 of 949",
        "group_2": "11 of 948",
        "difference": "0.8 points",
        "interval": "-0.3 to 2.1",
        "trial_title": "STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=187",
  "request_id": "FMhRqWY6vF8zWHRE"
}